News

Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense Pilots New Approach in Connecting with Innovators
May 26, 2023 — On 3 May 2023 the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) held their Textile and Protective Clothing Innovation Meeting hosted by the United States Patent and Trademark Office (USPTO) in Alexandria, Virginia. This meeting was a first-of-its-kind pilot project to encourage innovators to... MORE

Mr. Darryl Colvin, JPEO-CBRND, speaks to an audience as he stands next to a mannequin wearing the UIPE-FOS CBRN protective gear.

JPEO-CBRND Hosts CVCAD Exercise at Soldier Integration Facility
May 26, 2023 — With threats evolving, equipping warfighters to be ready to respond to several seen and unseen threats without increasing their physical burden, remains a top priority for the Department of Defense (DOD). The Compact Vapor Chemical Agent Detector (CVCAD) is a program of record that is currently funded and managed by the Joint Program Executive... MORE

one woman wearing a hijab and one man wearing a hat work to equip a mannequin with man-portable CBRN sensors gear.

Pacific Air Forces Airmen Test Next Generation Aircrew Protection Equipment
May 24, 2023 — If you’ve spent time in the Indo-Pacific region, you’ve heard the term “Fight Tonight,” probably more than once, and for good reason. Pacific Air Forces Airmen are on the forefront of operations in ensuring a free and open Indo-Pacific and in doing so, it comes with a need to be ready, diverse, innovative and lethal. We have been charged with... MORE

Airmen stands in hangar wearing CBRND pilot gear

Capacity Expansion Team Bolsters Nation’s Vaccine Industrial Base in Response to COVID-19
April 27, 2023 — At the height of the COVID-19 pandemic, supply chain shortfalls prevented Americans from finding basic items like toilet paper and cleaning supplies. Factory shutdowns emphasized the fact that most American manufacturing took place overseas. The domino effect was felt far and wide and was further illuminated once COVID-19 vaccines were available to... MORE

Crystal Tyler, pharmacy technician, prepares an injection for an Operation Warp Speed patient volunteer at Brooke Army Medical Center, Fort Sam Houston, Texas, November 16, 2020. BAMC and Wilford Hall Ambulatory Surgical Center are participating in the Phase III trial to evaluate the vaccine under development by AstraZeneca as part of a national initiative to accelerate the development, production and distribution of COVID-19 vaccines, therapeutics and diagnostics.

Lawyers and Pandemic Response: How the Joint Assisted Acquisition (JA2) Legal Cell Joined the Fight Against COVID-19
April 18, 2023 — President Biden announced that in May 2023, the U.S. will officially end its emergency response posture to the COVID-19 pandemic. This announcement marks a significant milestone in a long and difficult journey. From masks, to at-home test kits, to vaccines, countless experts worked tirelessly behind the scenes to develop the products and solutions... MORE

Ten people in business attire stand in front of flags and hold certificates of appreciation and award for service.

Medical Countermeasure Autoinjector Summit Held to Promote Performer and Joint Force Alignment
March 21, 2023 — On January 26, the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense’s (JPEO-CBRND) Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical) team hosted an autoinjector-focused summit, held at the Defense Health Agency Headquarters in Falls Church, Virginia.With the... MORE

COL Clark speaking at a podium in front of a group of a seated audience

Mobile Chem-Bio Detection Lab Now Fielded in all 50 States, Territories
February 15, 2023 — The mobile laboratory used for detecting and identifying chemical and biological hazards has now been delivered to all National Guard Bureau’s Weapons of Mass Destruction - Civil Support Teams (CST) in all 50 U.S. states, as well as the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands. Named the Analytical Laboratory System -... MORE

Members of the CBRN Defense community sit down during a presentation to celebrate the Analytical Laboratory System - Modification Work Order's achievement of full operational capacity

Batts Formally Recognized as the Defense Department’s Joint Project Manager for CBRN Protection
January 30, 2023 — Steven G. Batts, with over 38 years of service in the Defense Department and on active duty, formally assumed the charter on 20 December 2022 as the Joint Project Manager for Chemical, Biological, Radiological and Nuclear Protection (JPM CBRN Protection). In this role, Batts is responsible for the development, fielding, and modernization of... MORE

Steven G. Batts holds assumption of charter while shaking hands with Darryl J. Colvin

Senior Response Leaders Shown Latest Chemical, Biological Defense Technology Available for Disaster Response
December 22, 2022 — A group of senior leaders responsible for carrying out national disasters responses were recently shown the latest capabilities for responding to chemical, biological, radiological and nuclear (CBRN) events. On November 30, personnel from the Joint Program Executive Office for CBRN Defense along with the Air Force CBRN Defense Systems Branch and the Uniformed Services University’s 4DBio Program demonstrated current and future CBRN defense capabilities to a senior leadership team comprised of representatives from the White House’s Office of Science and Technology Policy, the National Security Council’s Office for Resilience and Response, the Defense Threat Reduction Agency, the Federal Emergency Management Agency (FEMA), and additional domestic emergency response organizations... MORE

Senior response leaders learn about the joint expeditionary collective protection family of systems available in the event of chemical or biological event

DoD Funds Production of More Life-Saving Medicine for Use After Nerve Agent Exposure
December 22, 2022 — The Defense Department's office responsible for acquiring medical countermeasures against chemical, biological, radiological and nuclear (CBRN) threats has awarded an agreement for the production of more life-saving nerve agent exposure treatments. The Joint Project Manager for CBRN Medical (JPM CBRN Medical) awarded a follow-on other transaction authority production agreement to Rafa Laboratories, Ltd. (Rafa) to manufacture and deliver 10mg midazolam injection autoinjectors to the Joint Force beginning December 2022. The midazolam injection autoinjector is indicated to treat prolonged seizures in adults, which can occur after exposure to a nerve agent. This new Advanced Anticonvulsant System (AAS) improves upon, and will eventually replace, the currently fielded Convulsant Antidote for Nerve Agent (CANA) diazepam autoinjector. Fielding the midazolam injection autoinjector gives the warfighter and the Nation access to a life-saving medical countermeasure in CBRN environments... MORE

News Search

News Archive - Search by Year and Month

May 2023 (3)
April 2023 (2)
March 2023 (1)
February 2023 (1)
January 2023 (1)
December 2022 (4)
November 2022 (1)
October 2022 (3)
September 2022 (5)
August 2022 (3)
July 2022 (3)
June 2022 (1)
May 2022 (1)
March 2022 (2)
February 2022 (2)
January 2022 (5)
December 2021 (1)
November 2021 (6)
October 2021 (2)
September 2021 (1)
July 2021 (1)
June 2021 (1)
May 2021 (8)
April 2021 (6)
March 2021 (2)
February 2021 (5)
January 2021 (4)
December 2020 (3)
November 2020 (1)
August 2020 (1)
July 2020 (3)
May 2020 (1)
April 2020 (1)
March 2020 (4)
February 2020 (1)
December 2019 (2)
November 2019 (2)
October 2019 (2)
September 2019 (2)
March 2019 (1)
January 2019 (2)
December 2018 (1)
October 2018 (1)
July 2018 (1)
April 2018 (1)
February 2018 (1)
December 2017 (1)
November 2017 (2)
September 2017 (1)
June 2017 (2)
January 2017 (3)
December 2016 (1)

JPEO-CBRND Press Kit

Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the JPEO-CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.

JPEO-CBRND Public Affairs Office

The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.